(Hepatitis C and Injection Drug Use in Sweden 2012) "In Sweden, the prevalence of hepatitis C among injecting drug users is very high. In various studies conducted during the last 15 years, the prevalence has been reported to be between 60% and 92%.
Statistics and other data regarding drugs and drug policies in Sweden, covering all areas including public safety/criminal justice, public health, prevention, treatment, and harm reduction.
(HIV and Injection Drug Use in Sweden) "Sexually transmitted infections, such as HIV, are not reported by full identity to the authorities in Sweden. This limits the possibility of following individuals over time and duplicates of notifications concerning the same individual may occur in the surveillance data.
(Treatment Clients in Sweden by Substance Used, 2012) "The distribution of drugs changed somewhat in 2008, with cannabis becoming more frequent than heroin. This trend has continued in data for the clients reported from treatment units in 2009: cannabis is now much more frequent than heroin.
"Amphetamine is still the most commonly used drug (29%) among the reported drug clients in treatment outside prisons, followed by cannabis (23%), heroin (17%), other opioids – analgesics and buprenorphine (11%) and benzodiazepines (11%).
(Number of Clients in Treatment in Sweden) "Data on treatment for problematic (or heavy) drug use at a national level is reported in TDI until 2010. In 2009 the reporting system covered 51% of all inpatient and 31% of all outpatient treatment centres. In 2010 the distribution should be similar even if the exact figures are not known.
(Estimated Number of Problem Drug Users in Sweden) "Based on register data from the patient register and from the Prison and Probation Services, it was estimated that there were 29,500 problematic drug users. This corresponds to 38 per cent of the 77,000 people who confirm regular use of illicit drugs in the population survey, or 23 per cent of the 127,000 people who regularly use some type of illicit drug or presomption medicine without a doctors prescriptive [sic].
(Women with Substance Abuse Problems in Sweden) "Drug users, both men and women, are often unemployed, homeless and frequently at the margins of society. Moreover, female drug users most often have less social support and a worse mental health compare to male regular drug users. Most research does not differentiate between genders in their analyses and focus is usually on the male subjects. Women normally make up 20 - 35 % of the subjects in most published studies; however, women often have a more serious addiction.
(Previous Estimates of Problem Drug Use in Sweden) "Individuals with drug use that could be categorised as problematic are generally a hard-to-reach population, making it difficult to obtain a picture of population size and development. Sweden also lacks a well-established definition of problematic or harmful drug use. In order to reach a more accurate picture of the Problem Drug Use (PDU) population size, as well as their living conditions, three nationwide studies were conducted in 1979, 1992 and 1998.
(Availability and Prices of Drugs in Sweden) "The availability of cannabis resin is judged to have increased over the past 20 years. Both economic availability and physical supply have increased. This assessment is based on the fact that seizures and court cases involving cannabis have increased sharply, at the same time as prices have fallen. However, data for 2010 indicates that this trend may have been broken in that the prices for cannabis resin rose and seizures decreased somewhat.
(Police Authority to Order Drug Tests) "Since drug use is prohibited with a maximum of six months imprisonment, the police are allowed to conduct drug tests (blood or urine) if there is reasonable cause to believe that a person is under the influence of drugs, however not on persons younger than 15 years old. The conservatives have however suggested a change in the legislation so that also these persons could be tested, in order to detect and stop drug use among young teenagers at an early stage.